Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JEFFREY J GLASS

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1760443261
CMS profile
351693
Location
HIGHLAND PARK, IL

General Payments · PY2018–2023

$8,023.32

  • Reported across 465 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$267.02

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $250.48 14
Education $16.54 1

By paying entity

PY2023 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,264.25 86
PY2019 $1,857.26 94
PY2020 $1,864.40 103
PY2021 $1,817.13 116
PY2022 $953.26 51
PY2023 $267.02 15

Payment records · PY2023 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2023 20182019202020212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amarin Pharma Inc. $14.58 02/06/2023 Food and Beverage Undisputed 01/23/2026 1000881477 CMS
AstraZeneca Pharmaceuticals LP $15.70 01/27/2023 Food and Beverage Undisputed 01/23/2026 1011827291 CMS
AstraZeneca Pharmaceuticals LP $14.25 02/01/2023 Food and Beverage Undisputed 01/23/2026 1015921333 CMS
AstraZeneca Pharmaceuticals LP $19.49 03/01/2023 Food and Beverage Undisputed 01/23/2026 1014872555 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.22 05/31/2023 Food and Beverage Undisputed 01/23/2026 996619775 CMS
Esperion Therapeutics, Inc. $21.27 04/12/2023 Food and Beverage Undisputed 01/23/2026 1050738285 CMS
Exact Sciences Corporation $15.40 05/03/2023 Food and Beverage Undisputed 01/23/2026 1026545545 CMS
Kowa Pharmaceuticals America, Inc. $14.29 01/31/2023 Food and Beverage Undisputed 01/23/2026 1003762339 CMS
Kowa Pharmaceuticals America, Inc. $15.98 02/14/2023 Food and Beverage Undisputed 01/23/2026 1003762347 CMS
Kowa Pharmaceuticals America, Inc. $16.24 03/08/2023 Food and Beverage Undisputed 01/23/2026 1003762355 CMS
Lilly USA, LLC $23.50 05/10/2023 Food and Beverage Undisputed 01/23/2026 1031622993 CMS
Novo Nordisk Inc $22.52 03/21/2023 Food and Beverage Undisputed 01/23/2026 1000950825 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.45 02/09/2023 Food and Beverage Undisputed 01/23/2026 1055392493 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.59 03/30/2023 Food and Beverage Undisputed 01/23/2026 1055392495 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.54 03/30/2023 Education Undisputed 01/23/2026 1055392497 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.